golexanolone
PreclinicalSmall molecule
golexanolone is one of 4 small molecule programs targeting Primary Biliary Cholangitis (PBC). It is currently in Preclinical.
1
Indications
1
Total Trials
1
Active Trials
3
Competitors
Pipeline
Status by Indication[3][1]
Indication
Competition
Competitive Landscape
3 competitors in Primary Biliary Cholangitis (PBC)
#DrugCompanyPhaseTrials
1Iqirvo
IpsenPhase 3
Rinvoq
AbbViePhase 2
Tricor
JJagotec
Phase 1
golexanolone
UUmecrine Cognition AB
Preclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Expected Milestones
Clinical
Trials by Indication[1]
Primary Biliary Cholangitis (PBC)1 trial
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for golexanolone. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details
Drug Info
Quick Facts
- Modality
- Small molecule[2]
- Highest Phase
- Preclinical[1]
- Company
- UUmecrine Cognition AB